Back to Search
Start Over
A matter of public interest
- Source :
- BMJ. 341:c3721-c3721
- Publication Year :
- 2010
- Publisher :
- BMJ, 2010.
-
Abstract
- Bevacizumab is better than no treatment, photodynamic treatment, or six weekly intravitreal pegaptanib sodium in neovascular age related macular degeneration (AMD).1 Its long term safety and whether it is as effective as ranibizumab are unknown,2 but available data should be sufficient for the European Medicine Agency (EMA) to …
- Subjects :
- medicine.medical_specialty
genetic structures
Bevacizumab
business.industry
General Engineering
General Medicine
Macular degeneration
medicine.disease
eye diseases
Antibodies monoclonal
Age related
Ophthalmology
Pegaptanib Sodium
General Earth and Planetary Sciences
Medicine
sense organs
Long term safety
Ranibizumab
business
General Environmental Science
medicine.drug
Subjects
Details
- ISSN :
- 14685833 and 09598138
- Volume :
- 341
- Database :
- OpenAIRE
- Journal :
- BMJ
- Accession number :
- edsair.doi...........6c230fe7815ccb8145a0dc3ab0a2615b